Player FM - Internet Radio Done Right
Checked 3d ago
تمت الإضافة منذ قبل four أعوام
المحتوى المقدم من The Uromigos. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Uromigos أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
E
Exile


1 Episode 21: The Heiress Who Helped End School Segregation 35:10
35:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب35:10
Hilde Mosse comes from one of the wealthiest families in Berlin and stands to inherit an enormous fortune. But she longs for something more meaningful than the luxurious lifestyle her family provides. So Hilde decides to pursue her dream of becoming a doctor. As the Nazis take power in Germany and the Mosse family is forced to flee, Dr. Hilde Mosse lands in New York having nearly lost everything.. She finds her calling treating the mental health of Black youth – and the symptoms of a racist system. In addition to photographs, school records, and correspondence spanning Hilde Mosse’s entire lifetime, the Mosse Family Collection in the LBI Archives includes the diaries she kept between 1928 and 1934, from the ages of 16-22. Hilde’s papers are just part of the extensive holdings related to the Mosse Family at LBI. Learn more at lbi.org/hilde . Exile is a production of the Leo Baeck Institute, New York and Antica Productions. It’s narrated by Mandy Patinkin. This episode was written by Lauren Armstrong-Carter. Our executive producers are Laura Regehr, Rami Tzabar, Stuart Coxe, and Bernie Blum. Our producer is Emily Morantz. Research and translation by Isabella Kempf. Voice acting by Hannah Gelman. Sound design and audio mix by Philip Wilson. Theme music by Oliver Wickham. Please consider supporting the work of the Leo Baeck Institute with a tax-deductible contribution by visiting lbi.org/exile2025 . The entire team at Antica Productions and Leo Baeck Institute is deeply saddened by the passing of our Executive Producer, Bernie Blum. We would not have been able to tell these stories without Bernie's generous support. Bernie was also President Emeritus of LBI and Exile would not exist without his energetic and visionary leadership. We extend our condolences to his entire family. May his memory be a blessing. This episode of Exile is made possible in part by a grant from the Conference on Jewish Material Claims Against Germany, which is supported by the German Federal Ministry of Finance and the Foundation Remembrance, Responsibility and Future.…
Episode 333: The Uromigos Cup - The Netherlands
Manage episode 427384781 series 2818403
المحتوى المقدم من The Uromigos. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Uromigos أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Axel Bex, Christian Blank, Laura Mertens and Micheil Van der Heijden answer a range of relevant and sometimes irrelevant questions
…
continue reading
392 حلقات
Manage episode 427384781 series 2818403
المحتوى المقدم من The Uromigos. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Uromigos أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Axel Bex, Christian Blank, Laura Mertens and Micheil Van der Heijden answer a range of relevant and sometimes irrelevant questions
…
continue reading
392 حلقات
كل الحلقات
×
1 Episode 392: ASCO GU 2025 - HIF Inhibition with Casdatifan in Refractory RCC 30:09
30:09
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:09
Toni Choueiri discusses the updated data from different cohorts of this novel HIF inhibitor.

1 Episode 391: ASCO GU 2025 - KIM-1 Data from Checkmate 214 23:28
23:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:28
Vincent Xu discusses this emerging RCC biomarker and data from the Checkmate 214 trial

1 Episode 390: ASCO GU 2025 - Pembro-based Doublets in Refractory RCC and COSMIC-313 OS Update 30:03
30:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:03
Laurence Albiges joins the show to discuss novel combos in refractory RCC and an update of the Ipi/Nivo/Cabo COSMIC OS data

1 Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer 25:28
25:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:28
Gopa Iyer from MSKCC joins the show to discuss his initial results from this phase 2 trial.

1 Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results 27:07
27:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:07
Xinan Sheng. M.D., Professor in the Department of Genitourinary Oncology at Peking University Cancer Hospital &institute in Beijing, China joins us to discuss the update of this trial and impressive pCR rates.

1 Episode 389: ASCO GU 2025 - NIAGARA Pathologic CR Updates and Outcomes 28:23
28:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب28:23
Matt Galsky joins the show to discuss pCR in NIAGARA and clinical implications.

1 Episode 386: ASCO GU 2025 - APRI Meta-analysis 28:58
28:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب28:58
Tanya Dorff from City of Hope joins us to discuss clinical implications of these data and also comment on TALAPRO-2
Neeraj Aggarwal joins Tom and Brian for an in-depth look at these important data
Silke Gillessen joins Brian and Tom and they discuss what to look forward to in prostate, bladder and RCC at ASCO GU 2025.

1 Episode 383: A Neoantigen Vaccine Generates Anti-tumor Immunity in RCC 33:11
33:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:11
David Braun joins the show to discuss his Nature paper on a personalized RCC vaccine

1 Episode 382: Uromigos Japan - TROPICs-04の考察 29:48
29:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب29:48
残念ながらNegative StudyとなったTROPICs-04についてUromigos Japanの3人が忖度なしに、その原因や理由について考察をします!!

1 Episode 381: Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade 40:05
40:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب40:05
Romain Banchereau joins the show to discuss and debate this Cancer Cell paper on molecular subtypes in urothelial cancer and implications for checkpoint blockade.
Shankar Siva joins the show to discuss the emerging role of stereotactic body radiotherapy (SBRT) in primary and metastatic RCC tumors.

1 Episode 379: Uromigos Japan: 2024年のGU Oncologyを振り返る 31:31
31:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:31
3人による2024年のGU oncoloyのレビューを切れ味鋭く解説しています。乞うご期待!

1 Episode 378: 2025 Preview of Important GU Data 41:42
41:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب41:42
Tanya Dorff from City of Hope joins Brian and Tom to review what to expect throughout 2025 and beyond in terms of clinically impactful data in prostate, renal and bladder cancer
T
The Uromigos

1 Episode 375: Renal Cancer 2024 Highlights 43:11
43:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب43:11
David McDermott (and his dog, Finn) join the show to review the top data from 2024 in RCC
T
The Uromigos

1 Episode 376: Bladder Cancer 2024 Highlights 25:37
25:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:37
Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer form the past year.
T
The Uromigos

1 Episode 377: Prostate Cancer 2024 Highlights 35:12
35:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب35:12
Silke Gilleson gives Tom and Brian 3 'gifts': Thomas Zilli (Radiation Oncology), Jochen Walz (Urology) and Ken Hermann (Nuclear Medicine) who discuss the 2024 prostate highlights from each of their unique perspectives.
T
The Uromigos

1 Episode 374: Mechanisms of HIF Resistance 34:37
34:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:37
Jim Brugarolas joins to discuss his talk from IKCS 2024 and the board topic of resistance to HIF inhibitors.
T
The Uromigos

1 Episode 373: KEYNOTE-564 Asian OSとANNARの解説 34:05
34:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:05
JSCO2024で発表されたKEYNOTE-564東アジア人OSデータとANNAR biomarker studyの解説とディスカッションです
T
The Uromigos

1 Episode 372: FDA Accelerated Approval Process 31:30
31:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:30
Dan Suzman from FDA joins us to discuss the Accelerated Approval process, requirements, successes and challenges.
T
The Uromigos

1 Episode 371: TROPICS-04 Results from ESMO Asia 33:43
33:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:43
Jonathan Rosenberg joins Brian and Tom to discuss this important phase 3 trial and efficacy and toxicity signals.
T
The Uromigos

1 Episode 370: Artificial Intelligence in Medical Oncology 44:46
44:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب44:46
Jacob Kather joins Brian and Tom to discuss emerging AI applications in Oncology
T
The Uromigos

1 Episode 369: Paper of the Month with Bishoy Faltas 45:51
45:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب45:51
Bishoy joins us to discuss his work on extrachromosomal DNA in bladder cancer from his latest Nature publication
T
The Uromigos

1 Episode 368: Radiomics in RCC: Live from IKCS 37:00
37:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب37:00
Andrew Smith from St. Jude's joins us to discuss the emerging field of radiomics and shares his hopes and skepticism
T
The Uromigos

1 Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer 56:48
56:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب56:48
Chuck Ryan from MSKCC joins to talk about various aspects of AR inhibition in prostate cancer and relative benefits and risks.
T
The Uromigos

1 Episode 366: ARPIs in Prostate Cancer - Are They Different? 31:51
31:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:51
Chris Sweeney and Rob Jones join Brian and Tom to discuss the relative merits of different ARPIs in prostate cancer.
T
The Uromigos

1 Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC) 47:59
47:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب47:59
Episode 365: Silke Gillessen and Betrand Tombal join the show to discuss the APCCC meeting and recent publication.
T
The Uromigos

1 Episode 364: 腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜 15:41
15:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب15:41
腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜
T
The Uromigos

1 Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜 14:23
14:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:23
前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.